摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-N-<3-(4-acetylphenyl)-5-hydroxymethyl-2-oxooxazolidinine> | 121466-43-1

中文名称
——
中文别名
——
英文名称
(R)-N-<3-(4-acetylphenyl)-5-hydroxymethyl-2-oxooxazolidinine>
英文别名
5(R)-hydroxymethyl-3-(4-acetylphenyl)-oxazolidin-2-one;(5R)-3-(4-acetylphenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one
(R)-N-<3-(4-acetylphenyl)-5-hydroxymethyl-2-oxooxazolidinine>化学式
CAS
121466-43-1
化学式
C12H13NO4
mdl
——
分子量
235.24
InChiKey
ZAEPGMOWWSWNQU-LLVKDONJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    425.7±28.0 °C(predicted)
  • 密度:
    1.295±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    66.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型抗菌剂dup 721的手性合成
    摘要:
    描述了由4-乙酰基异氰酸酯()和(R)-丁酸缩水甘油酯()合成DuP 721 [(S)-N- [3-(4-乙酰苯基)-2-氧代-5-恶唑烷基甲基]乙酰胺]的手性合成方法。。
    DOI:
    10.1016/0040-4020(89)80130-9
  • 作为产物:
    描述:
    (R)-<3-(4-acetylphenyl)-2-oxo-5-oxazolidinyl>methyl butyrate 在 sodium methylate 甲醇 作用下, 反应 2.0h, 以95%的产率得到(R)-N-<3-(4-acetylphenyl)-5-hydroxymethyl-2-oxooxazolidinine>
    参考文献:
    名称:
    新型抗菌剂dup 721的手性合成
    摘要:
    描述了由4-乙酰基异氰酸酯()和(R)-丁酸缩水甘油酯()合成DuP 721 [(S)-N- [3-(4-乙酰苯基)-2-氧代-5-恶唑烷基甲基]乙酰胺]的手性合成方法。。
    DOI:
    10.1016/0040-4020(89)80130-9
点击查看最新优质反应信息

文献信息

  • Oxazolidinone compounds and pharmaceutical compositions containing them
    申请人:AstraZeneca AB
    公开号:EP1357122A2
    公开(公告)日:2003-10-29
    The current invention provides an in-vivo hydrolysable ester of a compound of the formula (I) or a pharmaceutically-acceptable salt thereof; wherein X is -O- or -S-; HET is an optionally substituted C-linked 6-membered heteroaryl ring containing 1 or 2 N; Q is Q1 and T is for example:
    当前发明提供了化合物(I)的体内可水解酯或其药用可接受的盐;其中X为-O-或-S-;HET为含有1或2个N的可选择取代的C-连接的6元杂环芳基环;Q为Q1,T为例如:
  • Stereocontrolled, Divergent, Al(lll)-Catalyzed Coupling of Chiral <i>N</i>-Aryl Epoxy Amines and CO<sub>2</sub>
    作者:Yuseop Lee、Jonghoon Choi、Hyunwoo Kim
    DOI:10.1021/acs.orglett.8b02186
    日期:2018.8.17
    achieved between N-aryl epoxy amines and CO2. By using two different cocatalysts, tetrabutylammonium iodide (TBAI) or 4-dimethylaminopyridine (DMAP) together with an Al(III) Lewis acid, cyclic carbonates or oxazolidinones were selectively produced through two distinct reaction pathways, respectively. The proposed reaction mechanism was supported by the stereochemical determination of the products. A
    N-芳基环氧胺与CO 2之间发生了发散性偶联反应。通过使用两种不同的助催化剂,碘化四丁基铵碘化物(TBAI)或4-二甲基氨基吡啶(DMAP)以及Al(III)Lewis酸,分别通过两种不同的反应途径选择性地生产环状碳酸酯或恶唑烷酮。所提出的反应机理得到产物的立体化学测定的支持。成功实现了克利奈唑胺的克级生产。
  • Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The B group
    作者:Walter A. Gregory、David R. Brittelli、C. L. J. Wang、Mark A. Wuonola、Ronald J. McRipley、David C. Eustice、Virginia S. Eberly、Andrew M. Slee、Martin Forbes、P. T. Bartholomew
    DOI:10.1021/jm00128a003
    日期:1989.8
    The synthesis and structure/activity studies of the effect of varying the "B" group in a series of oxazolidinone antibacterials (I) are described. Two synthetic routes were used: (1) alkylation of aniline with glycidol followed by dialkyl carbonate heterocyclization to afford I (A = H, B = OH), whose arene ring was further elaborated by using electrophilic aromatic substitution methodology; (2) cycloaddition of substituted aryl isocyanates with epoxides to give A and B with a variety of values. I with B = OH or Br were converted to other "B" functionalities by using SN2 methodology. Antibacterial evaluation of compounds I with A = acetyl, isopropyl, methylthio, methylsulfinyl, methylsulfonyl, and sulfonamido and a variety of different "B" groups against Staphylococcus aureus and Enterococcus faecalis concluded that the compounds with B = aminoacyl, and particularly acetamido, were the most active of those examined in each A series, possessing MICs in the range of 0.5-4 micrograms/mL for the most active compounds described.
  • WANG, CHIA-LIN J.;GREGORY, WALTER A.;WUONOLA, MARK A., TETRAHEDRON , 45,(1989) N, C. 1323-1326
    作者:WANG, CHIA-LIN J.、GREGORY, WALTER A.、WUONOLA, MARK A.
    DOI:——
    日期:——
  • OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    申请人:AstraZeneca AB
    公开号:EP1082322A2
    公开(公告)日:2001-03-14
查看更多